Travelers to and residents of endemic regions of Plasmodium falciparum can become infected and develop severe disease which is associated with significant morbidity and mortality, despite receiving antimalaria therapy. Upon conclusion of this study we will determine the role of a malaria phospholipase A2 in mediating brain swelling to potentially develop needed adjunctive therapy to improve health outcomes of cerebral malaria.
